Urinary Citrate Is Associated with Kidney Outcomes in Early Polycystic Kidney Disease-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Urinary Citrate Is Associated with Kidney Outcomes in Early Polycystic Kidney Disease

Published:2022-12 Issue:12 Volume:3 Page:2110-2115
ISSN:2641-7650
Container-title:Kidney360
language:en
Short-container-title:Kidney360

Author:

Rocha Daniel Ribeiro,Xue Laixi,Gomes Sousa Hiago Murilo,Carvalho Matos Ana Christina,Hoorn Ewout J.,Salih Mahdi,Heilberg Ita Pfeferman

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Medicine

Reference18 articles.

1. Evaluation of nephrolithiasis in autosomal dominant polycystic kidney disease patients;Nishiura;Clin J Am Soc Nephrol,2009

2. Renal stone disease in autosomal dominant polycystic kidney disease;Torres;Am J Kidney Dis,1993

3. Crystal deposition triggers tubule dilation that accelerates cystogenesis in polycystic kidney disease;Torres;J Clin Invest,2019

4. Urinary citrate as a marker of renal function in patients with autosomal dominant polycystic kidney disease;Borrego Utiel;Int Urol Nephrol,2022

5. Hypocitraturia is present when renal function is impaired in diverse nephropathies and is not related with serum bicarbonate levels;Borrego Utiel;Int Urol Nephrol,2022

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Urine pH-Ammonium Acid/Base Score and CKD Progression;Journal of the American Society of Nephrology;2024-07-17

2. Kidney Stones Account for Increased Imaging Studies in Autosomal Dominant Polycystic Kidney Disease;Kidney360;2024-03-25

3. The citrate transporter SLC13A5 as a therapeutic target for kidney disease: evidence from Mendelian randomization to inform drug development;BMC Medicine;2023-12-18

4. A Combination of ß-Hydroxybutyrate and Citrate Ameliorates Disease Progression in a Rat Model of Polycystic Kidney Disease;American Journal of Physiology-Renal Physiology;2023-12-14

5. Beyond Loss of Kidney Function: Patient Care in Autosomal Dominant Polycystic Kidney Disease;Kidney360;2023-11-27

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3